Training Courses

In this advanced course, trainees develop greater understanding of upstream processing techniques with a particular focus on emerging trends and disruptive technologies. Course content is tailored toward mammalian cell lines, with a larger focus placed on suspension and intensified systems. Learning achieved by lectures, classroom activities and laboratory demonstrations.

This 5-day comprehensive training course offers an end-to-end exploration of the biomanufacturing process, integrating both upstream and downstream operations into a unified, hands-on learning experience. Participants will begin by cultivating a recombinant protein using a microbial expression system in a 30 L stainless steel stirred-tank bioreactor, gaining direct experience in bioreactor setup, sterilisation, inoculation, monitoring, and harvest procedures.

The course is aimed at early career professionals and anyone who wants to develop an understanding of upstream biomanufacturing techniques and processes.This 3-day course consists of six lectures, enhanced with practical demonstrations using bench-scale, pilot-scale, and single-use bioreactors. In particular, attendees will gain hands-on fermentation experience using a 30L-scale, stainless steel, stirred tank bioreactor.

Learn how experimental design techniques can be used to rapidly understand and optimise bioprocess performance.

Efficiency, compliance, and precision form the foundation of Good Manufacturing Practice (GMP) in medicines manufacturing. This course will provide practical experience through immersive VR to help you appreciate how the right combination of equipment, materials handling strategies, and process controls come together to meet the sector's stringent regulatory standards and ensure the reliable delivery of safe, high-quality medicines to patients worldwide.

Gain hands-on experience in the set-up and aseptic operation of single-use bioreactors for the culture of mammalian cells.

This course, delivered in partnership with Cytiva, will examine process technologies and their operation for end-to-end ATMP production.

Learn the safe set-up and operation of microbial bioreactors and the underlying techniques of aseptic lab work. This hands-on course is designed to provide delegates with a practical understanding and operation of lab-scale microbial bioreactors.

This 4-day intensive training course is designed for professionals and researchers looking to advance their expertise in large-scale upstream bioprocessing, with a focus on scale-up to 300 L pilot-scale operations. Participants will explore the principles and practical steps involved in scaling microbial cell culture to production-relevant volumes, supported by expert-led lectures, live demonstrations, and hands-on training.

In this introductory course, trainees develop the hands-on skills required to perform within an upstream bioprocessing development role. Course content is tailored toward mammalian cell culture of CHO and HEK cells. Learning achieved lectures, classroom activities and lab based practicals.

Focusing on how to specify the process and the fundamentals for characterisation, this module will strengthen your knowledge of fermentation processes and through a series of lectures and case studies.

Get expert guidance on choosing on how best to integrate QbD, DoE and PAT into lifecycle approach to process characterisation and operation of lab-scale microbial bioreactors. 4-days of training featuring a series of stimulating interactive lectures from experts in the field and teamwork-based activities.

This module focuses on the design and specification of bioreactors and the application of microscale techniques for rapid fermentation process development and scale-up.

Delivered in collaboration with Massachusetts Institute of Technology (MIT), this three-day in-person workshop will explore the critical issues at the various stages of vaccine development. International experts will lead delegates in developing their understanding in the research, operational, and regulatory challenges of the vaccine market.